U.S. Physical Therapy, Inc.

NYSE:USPH Stock Report

Market Cap: US$1.4b

U.S. Physical Therapy Management

Management criteria checks 3/4

U.S. Physical Therapy's CEO is Chris Reading, appointed in Nov 2004, has a tenure of 20.08 years. total yearly compensation is $3.37M, comprised of 28.4% salary and 71.6% bonuses, including company stock and options. directly owns 0.63% of the company’s shares, worth $8.75M. The average tenure of the management team and the board of directors is 6.8 years and 17.3 years respectively.

Key information

Chris Reading

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage28.4%
CEO tenure20.1yrs
CEO ownership0.6%
Management average tenure6.8yrs
Board average tenure17.3yrs

Recent management updates

Recent updates

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

Oct 13
Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Sep 05
U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Aug 15
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01
Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07
At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01
U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04
Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24
Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20
We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05
Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

CEO Compensation Analysis

How has Chris Reading's remuneration changed compared to U.S. Physical Therapy's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$14m

Jun 30 2024n/an/a

US$16m

Mar 31 2024n/an/a

US$18m

Dec 31 2023US$3mUS$959k

US$18m

Sep 30 2023n/an/a

US$24m

Jun 30 2023n/an/a

US$26m

Mar 31 2023n/an/a

US$28m

Dec 31 2022US$2mUS$926k

US$29m

Sep 30 2022n/an/a

US$39m

Jun 30 2022n/an/a

US$38m

Mar 31 2022n/an/a

US$37m

Dec 31 2021US$4mUS$896k

US$31m

Sep 30 2021n/an/a

US$31m

Jun 30 2021n/an/a

US$30m

Mar 31 2021n/an/a

US$32m

Dec 31 2020US$3mUS$676k

US$32m

Sep 30 2020n/an/a

US$30m

Jun 30 2020n/an/a

US$31m

Mar 31 2020n/an/a

US$29m

Dec 31 2019US$3mUS$769k

US$31m

Sep 30 2019n/an/a

US$30m

Jun 30 2019n/an/a

US$23m

Mar 31 2019n/an/a

US$18m

Dec 31 2018US$3mUS$739k

US$17m

Sep 30 2018n/an/a

US$18m

Jun 30 2018n/an/a

US$22m

Mar 31 2018n/an/a

US$21m

Dec 31 2017US$2mUS$720k

US$22m

Compensation vs Market: Chris's total compensation ($USD3.37M) is below average for companies of similar size in the US market ($USD5.51M).

Compensation vs Earnings: Chris's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Chris Reading (60 yo)

20.1yrs

Tenure

US$3,372,377

Compensation

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...

Leadership Team

NamePositionTenureCompensationOwnership
Christopher Reading
Chairman & CEO20.1yrsUS$3.37m0.63%
$ 8.8m
Eric Williams
President & COO3.4yrsUS$1.79m0.098%
$ 1.4m
Carey Hendrickson
Chief Financial Officer4.1yrsUS$1.69m0.14%
$ 1.9m
Richard Binstein
Executive VP13.9yrsUS$1.50m0.078%
$ 1.1m
Graham Reeve
Chief Operating Officer - West6.8yrsUS$1.91m0.13%
$ 1.8m
Jake Martinez
Senior Vice President of Finance & Accounting2.7yrsno datano data
Chadd Pence
Senior Vice President of Information Systemsno datano datano data
Jayne Pool
Senior VP & Chief Compliance Officerno datano datano data
Jason Anderson
Vice President of Human Resourcesno datano datano data
Jon Bates
VP & Corporate Controller18.1yrsno datano data

6.8yrs

Average Tenure

60yo

Average Age

Experienced Management: USPH's management team is seasoned and experienced (6.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christopher Reading
Chairman & CEO20.1yrsUS$3.37m0.63%
$ 8.8m
Nancy Ham
Independent Director1.6yrsUS$215.92k0.0074%
$ 101.6k
Clayton Trier
Independent Director19.8yrsUS$269.29k0.043%
$ 586.6k
Bernard Harris
Lead Independent Director19.3yrsUS$264.29k0.11%
$ 1.5m
Kathleen Gilmartin
Independent Director6.6yrsUS$256.54k0.13%
$ 1.7m
Reginald Swanson
Independent Director17.3yrsUS$236.54k0.13%
$ 1.7m
Anne Motsenbocker
Independent Director2.9yrsUS$239.04k0.037%
$ 513.6k

17.3yrs

Average Tenure

67yo

Average Age

Experienced Board: USPH's board of directors are seasoned and experienced ( 17.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

U.S. Physical Therapy, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PetuskyBarrington Research Associates, Inc.
Alexander ParisBarrington Research Associates, Inc.
Joanna Sylvia GajukBofA Global Research